AID Genomics Ltd.

AID Genomics is an international group of medical technology companies specialized in the diagnosis and therapy of cancer and infectious diseases like COVID-19.

AID Genomics’ advanced testing platforms were developed by a leading team of experts in oncology, molecular biology, molecular pathology, genomics and bioinformatics.

AID Genomics uses cutting-edge technology to substantially improve cancer patients' survival rate and quality of life by offering early detection solutions integrated with personalized preventive medicine. AID Genomics also offers a range of innovative mobile COVID-19 testing solutions, enabling increased mobility and transport options.